Dr. Charles R. Boice, MD

Dr. Boice practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Boice's NPI, 1740263425, was assigned on November 27, 2005. Dr. Boice graduated from Loma Linda University School Of Medicine in 1973. Dr. Boice holds Maryland license D0029142.

Dr. Boice's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Boice's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Boice is also affiliated with MedStar Franklin Square Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Boice to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boice practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Boice's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Boice is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Boice's licenses on file in 6 states: Maryland, District of Columbia, California, Virginia, Nevada and Texas.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Boice treats.

CMS data shows 271 Medicare services from Dr. Boice across 4 procedure codes in 2024, all of them office visits, for 186 Medicare patients. Medicare paid $27,496 for them.

CMS counts 186 Medicare patients who saw Dr. Boice in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boice's median patient age at 61, with 99% women.

In 2024, Dr. Boice wrote 124 Medicare Part D claims for 57 patients. 85% of them were for generic drugs. CMS names the drug for 74 of them, across 3 drugs with 11 or more claims each, at $2,372 in total drug cost. In 2023, CMS named 52 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Boice for performance year 2024, reported as part of a group. Dr. Boice accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of removal of the uterus by Dr. Boice, more than 96% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Boice, published from 2006 to 2010. The most frequent topics are Ovarian Neoplasms, Carcinoma and Carcinoma, Squamous Cell. Dr. Boice has published most often in Gynecol Oncol. Dr. Boice's most frequent co-authors are Ralph S. Freedman, MD, PhD, Jan Sivert Sunde, MD and Brant G. Wang, MD, PhD.

CMS Open Payments shows 33 general payments to Dr. Boice from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Davol Inc. paid the most, $408.

Dmand AI lists 8 awards for Dr. Boice, most recently America's Top Doctors in 2014.

Dr. Boice graduated from Loma Linda University School Of Medicine in 1973. Dr. Boice is a member of American College of Obstetricians and Gynecologists and ASCO.

Dr. Boice is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.